Home / Industries / Healthcare / Life Science Tools, Diagnostics and Laboratory Services / Specialized Diagnostic Services

HEALTHCARE INVESTMENT BANKING SERVICES

Maximizing Value in Specialty Diagnostics

Specialty diagnostic providers face relentless reimbursement cuts, regulatory scrutiny, and payer-driven pricing pressure. Oncology, cardiometabolic, pharmacogenomics, transplant, women’s health, and substance abuse testing all struggle to scale, secure contracts, and sustain margins.

Speak with a Senior Advisor

Hyde Park Capital positions these platforms as strategic assets by showcasing recurring revenue, clinical adoption, and payer ties. Our senior-led process connects clients with leading acquirers, withstands regulatory volatility, and delivers premium valuations with lasting market strength.

HEALTHCARE INVESTMENT BANKING: Specialized Diagnostics

Expertise in Oncology Testing

Oncology diagnostic labs face margin pressure from prior-authorization friction, shifting CPT codes, and payer denials that delay reimbursement and slow growth. Hyde Park Capital helps operators secure durable payer coverage, expand menus with high-margin assays through targeted M&A, and formalize referral pathways with oncology groups and health systems—driving faster cash conversion, steadier sample volume, and premium valuations supported by contracted recurring revenue.

Expertise in Cardiometabolic Screening

Cardiometabolic testing providers face long adoption cycles, expensive equipment needs, and payer scrutiny that stall growth and compress margins. Hyde Park Capital helps operators accelerate adoption, strengthen recurring revenue models, and execute efficient growth capital strategies. By highlighting predictable utilization and customer stickiness, we position platforms for premium valuations and sustainable leadership in this evolving market.

Expertise in Pharmacogenomics

PGx labs navigate unpredictable test volumes, evolving regulatory requirements, and payer uncertainty that complicate scaling. Hyde Park Capital helps operators secure growth capital, expand clinical pipelines, and execute M&A strategies that improve compliance and turnaround. This results in stronger reimbursement durability, higher-value assay portfolios, and valuations tied to clinical relevance and scalability.

Expertise in Women’s Health Diagnostics

Women’s health diagnostics face uneven reimbursement, patient access challenges, and fragmented referral networks that limit scalability. Hyde Park Capital helps operators strengthen payer contracts, expand into high-demand test areas, and build durable partnerships with health systems and OB/GYN groups. The outcome is steadier sample flow, stronger recurring revenue, and valuations reflecting long-term growth in a resilient specialty.

Expertise in Transplant Monitoring

Transplant diagnostics providers operate in a high-stakes, niche market where delayed adoption, complex reimbursement, and high compliance costs can limit growth. Hyde Park Capital helps operators secure payer alignment, expand clinical adoption, and pursue strategic M&A to scale efficiently. This creates predictable revenue streams, faster timelines to market acceptance, and premium valuations driven by essential clinical utility.

HEALTHCARE INVESTMENT BANKING TRANSACTIONS

Recent Healthcare Transactions

Check out our track record of previous Healthcare Transactions.

View All

Loading transactions...

Testimonials

“From the outset, Hyde Park Capital demonstrated an unparalleled level of expertise and dedication to our process. Their approach was not just about raising capital; it was about finding the right investors who shared our vision.”
Jim BoswellCEO, OnPoint Healthcare Partners

“We are eternally grateful to the entire Hyde Park Capital team and the work they have done throughout this entire process. We couldn’t have done it without them!”
Shane DonaldsonFounder and CEO, Pinnacle Homecare

“We at Toney HealthCare Consulting would like to formally thank the Hyde Park team for their determination and dedication in driving our process to a most successful outcome. Our endeavor would not have been possible without Hyde Park Capital.”
Dr. Sam ToneyFounder and CEO, Toney Healthcare Consulting

“We operate in a rapidly changing healthcare environment and this relationship bridged by Hyde Park Capital positions ACS to focus on our continued growth strategy, future opportunities, and diversification of our business model for many years.”
Roger BrownCEO, American Clinical Solutions

“I am extremely thankful to have had Hyde Park Capital in Pinnacle’s corner. The HPC team kept everyone aligned on the singular goal of creating a strategic partnership.”
Michael FroningPresident, Pinnacle Homecare

See More Testimonials

SENIOR HEALTHCARE INVESTMENT BANKERS

Meet HPC’s Experts

Meet our highly specialized team of healthcare investment bankers.

MANAGING PARTNER John Hill, Jr.

MANAGING DIRECTOR Michael Johnson

MANAGING DIRECTOR Chris Fieschko

MANAGING DIRECTOR T.J. Wallace

SENIOR VICE PRESIDENT Josh Paul

VICE PRESIDENT Joe Pennington

HEALTHCARE INDUSTRY REPORTS

See our latest Healthcare Industry Reports

Stay informed with our latest insights.

Loading Industry Reports...

Latest Reports

Stay Updated with M&A Reports

Sign up to receive the latest insights and updates on M&A activities in the Healthcare industry. Our reports are tailored to keep you informed and ahead in this dynamic sector.

HEALTHCARE INVESTMENT BANKING SECTORS

Supporting Growth Across All of the Healthcare Sectors

Hyde Park Capital partners with healthcare companies to unlock growth, attract strategic capital, and complete transactions that strengthen market position. We bring decades of sector expertise to identify opportunities and deliver results that build lasting enterprise value.

Our track record spans transactions across key healthcare sectors, including: